CTOs on the Move

Texas Lutheran University

www.tlu.edu

 
Texas Lutheran University in Seguin, Texas is consistently ranked a one of the regions top colleges by U.S. News & World Report and the Princeton Review. With a diverse student body of 1,400 and an array of undergraduate, graduate, and pre-professional programs, TLU offers small class sizes, individualized attention, and academic excellence. Founded in 1891, the private university sits on 184 picturesque acres in the heart of Sequin, which lies between San Antonio and Austin.
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.tlu.edu
  • 1000 W Court St
    Seguin, TX USA
  • Phone: 830.372.8000

Executives

Name Title Contact Details

Similar Companies

Parents In A Pinch

Parents In A Pinch is a Brookline, MA-based company in the Business Services sector.

TIXiMED

TIXiMED, Inc. is focused on developing and commercializing TXNIP inhibiting medication as a first-of-its-kind oral therapeutic for Type 1 and Type 2 diabetes. TIXiMED is the exclusive license holder for the patent (composition of matter and method of use) surrounding TIX100, a novel small molecule that normalizes pancreatic beta cell TXNIP, a detrimental protein elevated in Type 1 and Type 2 diabetes. Increased TXNIP causes pancreatic islet dysfunction and death of insulin-producing beta cells and thereby contributes to the development and progression of diabetes. Diabetes affects more than half a billion people worldwide. Those affected by Type 1 diabetes are dependent on multiple daily insulin injections or continuous insulin infusions to stay alive and manage their blood sugar. Oral anti-diabetic drugs are only approved for Type 2 diabetes, but can be associated with multiple side effects, underlining the need for novel and better oral diabetes medications for Type 1 and Type 2 diabetes. TXNIP inhibition has recently been demonstrated to be an effective and safe therapeutic approach in adults and children with recent onset Type 1 diabetes and TIX100 shows beneficial, anti-diabetic effects in 4 different mouse models. Advantages of TIX100 include oral availability, no associated hypoglycemia or weight gain, potent inhibition of detrimental TXNIP in human islets, and a favorable pharmacokinetic and safety profile. In addition, TIX100 inhibits excessive glucagon secretion and hepatic glucose production and protects against fatty liver. Thus, TIX100 holds promise for durable, weight-neutral improvement in glycemic control in Type 1 and Type 2 diabetes by targeting common underlying pathology and promoting patients own islet cell health.

Irys

As the only provenance layer, Irys emerges as the source of credibility in a turbulent sea of misinformation. By scaling permanent data and enabling users to precisely attribute its origin, Irys paves the way to incorporate accountability into all information. When data testifies its origin, trust reigns and misinformation becomes a tale of the past. Irys stands as a witness for humanity.

Chase Consulting Group

Chase Consulting Group is a Alexandria, VA-based company in the Business Services sector.